Pasar al contenido principal

TECNOLOGIAS EMERGENTES ALTERNATIVAS A LA PASTERIZACION HOLDER PARA BANCOS DE LECHE HUMANA: HOMOGENEIZACION A ULTRA ALTA PRESION Y RADIACION ULTRAVIOLETA DE ONDA CORTA UVC

PID2023-149923OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluation of Ultra-High Pressure Homogenization Treatments to Ensure the Microbiological Safety and Immunoglobulin Preservation in Donor Human Milk

  • Jalali, Kimia
  • Pastor-Villaescusa, Belén|||0000-0003-0817-6804
  • Flores-Rojas, Katherine|||0000-0001-8692-0702
  • Pleguezuelos, Vanessa
  • Pérez-Cano, Francisco J.|||0000-0001-6243-9164
  • Franch, Àngels|||0000-0002-2362-1374
  • Trujillo, Antonio-José|||0000-0003-1437-6060
  • Hernández Herrero, María Manuela|||0000-0003-0988-9179
  • Roig Sagués, Artur Xavier|||0000-0002-2410-6606
Most donor human milk (HM) banks use Holder pasteurization (HoP) to ensure microbiological safety, although it can degrade essential bioactive factors for newborns. This study evaluates the innovative ultra-high-pressure homogenization (UHPH) technology as a potential alternative. Listeria innocua, Staphylococcus carnosus, Franconibacter helveticus (formerly named Cronobacter helveticus) and Escherichia coli strains were used as surrogates for common HM pathogens according to European Milk Bank Association (EMBA) guidelines, to evaluate the efficacy of new technologies. A reconstituted powder milk formula inoculated with these strains was used to determine the most efficient conditions (those to achieve a lethality of ≥5 Log), applying treatments from 150 to 300 MPa. These treatments were later validated using inoculated HM with the same strains. Immunoglobulin (sIgA, IgG, IgM) retention was also evaluated and compared with HoP. Results showed that UHPH treatments at 200 MPa achieved a lethality.